Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX)
| Assets | $116.38M |
| Expense Ratio | 0.35% |
| PE Ratio | 17.23 |
| Shares Out | 4.90M |
| Dividend (ttm) | $0.14 |
| Dividend Yield | 0.58% |
| Ex-Dividend Date | Dec 23, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 10.04% |
| Volume | 24 |
| Open | 23.72 |
| Previous Close | 23.76 |
| Day's Range | 23.72 - 23.72 |
| 52-Week Low | 16.67 |
| 52-Week High | 25.07 |
| Beta | n/a |
| Holdings | 529 |
| Inception Date | Feb 27, 2025 |
About SMDX
Fund Home PageThe Intech S&P Small-Mid Cap Diversified Alpha ETF (SMDX) is an exchange-traded fund that mostly invests in extended market equity. The fund is an actively managed fund of US small- to mid-cap companies found in the S&P 1000 Index. It utilizes volatility, correlation, profitability, and valuations to identify and select stocks. SMDX was launched on Feb 27, 2025 and is issued by Intech ETFs.
Top 10 Holdings
10.29% of assets| Name | Symbol | Weight |
|---|---|---|
| Jones Lang LaSalle Incorporated | JLL | 1.38% |
| East West Bancorp, Inc. | EWBC | 1.14% |
| Tenet Healthcare Corporation | THC | 1.03% |
| Medpace Holdings, Inc. | MEDP | 1.02% |
| Coherent Corp. | COHR | 1.02% |
| Lamar Advertising Company | LAMR | 1.00% |
| US Foods Holding Corp. | USFD | 0.95% |
| nVent Electric plc | NVT | 0.94% |
| United Therapeutics Corporation | UTHR | 0.92% |
| Ormat Technologies, Inc. | ORA | 0.89% |
Performance
SMDX had a total return of 26.13% in the past year, including dividends. Since the fund's inception, the average annual return has been 18.20%.
News
Intech S&P Mid Cap Diversified Alpha ETF Surpasses $100 Million; Performance Underscores Structural Edge in SMID-Cap Core
One of Just 11% of Active ETFs to Surpass $100 Million in Year One WEST PALM BEACH, Fla. , Nov. 19, 2025 /PRNewswire/ -- The Intech S&P Mid Cap Diversified Alpha ETF (NYSE Arca: SMDX) has surpassed $1...
Intech Launches Next-Generation ETFs to Challenge Market Concentration
Intech launches ETFs to mitigate concentration risk, applying systematic rebalancing to maintain broad market exposure while optimizing diversification.